OverviewChartNewsTraderScreen

CorMedix Inc/  US21900C3088  /

IEX
6/7/2024  9:59:39 PM Chg. -0.04 Volume Bid- Ask- High Low
5.17USD -0.67% 2,719
Turnover: 13,967.38		 -Bid Size: - -Ask Size: - 5.20 5.09
GlobeNewswire 6/6 CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath
GlobeNewswire 5/28 CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider
GlobeNewswire 5/10 CorMedix Inc. to Participate in Two Upcoming Investor Conferences
GlobeNewswire 5/9 CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/6 CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9...
GlobeNewswire 4/19 CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
GlobeNewswire 4/15 CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Hepari...
GlobeNewswire 4/11 CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Confere...
GlobeNewswire 4/8 CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
GlobeNewswire 3/27 CorMedix Inc. to Present at the Needham Annual Healthcare Conference
GlobeNewswire 3/12 CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Upda...
GlobeNewswire 3/6 CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate ...
GlobeNewswire 1/30 CorMedix Inc. Announces Commercial and Reimbursement Updates
GlobeNewswire 1/8 CorMedix Inc. Announces Commercial and Operational Updates
GlobeNewswire 12/15/2023 CorMedix Inc. Announces Appointment of Chief Legal Officer
GlobeNewswire 12/4/2023 CorMedix Inc. Announces Partnership With The Leapfrog Group
GlobeNewswire 11/15/2023 CorMedix Inc. Announces FDA Approval of DefenCath® to Reduce the Incidence of Catheter-Related Blood...
GlobeNewswire 11/14/2023 CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Upda...
GlobeNewswire 11/2/2023 CorMedix Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on Novem...
GlobeNewswire 10/11/2023 CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference
GlobeNewswire 9/26/2023 CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
GlobeNewswire 9/8/2023 CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The...
GlobeNewswire 9/6/2023 CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference
GlobeNewswire 8/30/2023 CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath
GlobeNewswire 3/28/2022 CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath